Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan To Send Investigators To Europe On H1N1 Flu Vaccine Safety Mission

This article was originally published in PharmAsia News

Executive Summary

Following a decision to send investigators to Canada after a flu vaccine recall, Japan's Ministry of Health, Labor and Welfare has decided to send investigators to Europe to gather information on concerns of flu vaccine safety. The ministry will gather information on Novartis's H1N1 flu vaccine. The team plans to go to Switzerland or Germany, the two countries that currently approved the use of the vaccine, and assess adverse effects information. Novartis and UK drug maker GlaxoSmithKline have signed agreements to export flu vaccines to Japan for 49.5 million people. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts